Vivek Ramaswamy Net Worth

Vivek Ramaswamy has an estimated net worth of $2.2 billion, according to Forbes Real-Time Billionaires, Vivek Ramaswamy profile (figures as of October 20, 2026). That is up from $1 billion in 2025.

Vivek Ramaswamy is an American entrepreneur, author, and politician best known for founding Roivant Sciences. He studied biology at Harvard and law at Yale, then started on Wall Street trading biotech stocks for QVT. In 2014, he launched Roivant, a drug discovery and investment company. A big turning point came in 2015, when he took a speculative Alzheimer’s drug public in a $3 billion IPO that became the base for Roivant’s rise.

His wealth has come mainly from investments tied to biotech and finance. Roivant later helped bring multiple drug candidates to market, and positive Phase 3 results for brepocitinib lifted the company’s stock in late 2025. Ramaswamy left Roivant in 2020, wrote Woke, Inc., and then co-founded Strive Asset Management in 2022. He also ran for president in 2024 and is the Republican nominee for governor of Ohio in 2026.

How Vivek Ramaswamy built his fortune

Ramaswamy’s money story starts in investing. After Harvard, he went to QVT, where he traded biotech stocks and later became a partner. That gave him a close view of how drug companies were valued and financed. In 2014, he used that experience to start Roivant Sciences, a biotech company built around drug discovery, development, and investment. Roivant’s model focused on finding overlooked drug assets and building companies around them.

In 2015, he took public a speculative Alzheimer’s drug in a $3 billion IPO. The drug later failed, but that deal helped establish Roivant as a major platform. In the years that followed, Roivant backed multiple successful drug candidates, including brepocitinib, whose positive Phase 3 trial results pushed the stock sharply higher in late 2025. Ramaswamy stepped away from Roivant in 2020, then started Strive, an asset manager offering anti-woke investment funds.

What Forbes says about his net worth

Forbes estimated Ramaswamy’s wealth at $1 billion on its World’s Billionaires List in 2025. A year later, Forbes put him at $2.4 billion on the 2026 list. The rise matched a stronger period for Roivant, including the late 2025 jump in its stock after brepocitinib posted positive Phase 3 results. Forbes places him in Healthcare and describes him as self-made, with wealth tied to investments.

As of October 20, 2026, Forbes shows Ramaswamy at $2.2 billion on its real-time billionaires tracker. That real-time number is lower than the 2026 annual list figure, which shows how market prices can move over time. His money is still linked mainly to investment-driven businesses in biotech and finance, especially the company he founded, Roivant, and the asset management firm Strive that he launched after leaving Roivant.